Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999–2013

Published:2017-12-01 Issue:4 Volume:12 Page:315
ISSN:2211-8179
Container-title:Global Heart
language:
Short-container-title:gh

Author:

Kotseva Kornelia,De Bacquer Dirk,Jennings Catriona,Gyberg Viveca,De Backer Guy,Rydénz Lars,Amouyel Philippe,Bruthans Jan,Cifkova Renata,Deckers Jaap W.,De Sutter Johan,Fraz Zlatko,Graham Ian,Keber Irena,Lehto Seppo,Moore David,Pajak Andrzej,Wood David,EUROASPIRE Investigators On behalf of the

Publisher

Ubiquity Press, Ltd.

Subject

Cardiology and Cardiovascular Medicine,Community and Home Care,Epidemiology

Reference33 articles.

1. Draft Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020,2013

2. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results;Eur Heart J,1997

3. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme;Eur Heart J,2001

4. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group;Lancet,2001

5. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries;Kotseva;Eur J Cardiovasc Prev Rehabil,2009

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Long-Term Outcomes in STEMI Patients with New Left Bundle Branch Block: The Impact of Modifiable Risk Factors;Journal of Personalized Medicine;2024-07-19

2. Atorvastatin versus tetrahydrolipstatin in male patients with dyslipidemia: A systematic review and meta-analysis;Journal of Pharmacy & Pharmacognosy Research;2024-03-01

3. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2023-08-29

4. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease;Journal of the American College of Cardiology;2023-08

5. Association between control of cardiovascular risk factors and acute myocardial infarction among re-hospitalized young patients with prior coronary heart disease;Chinese Medical Journal;2023-05-09